Matching geography
Reports matching your search in:
 
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > South America
Category: All Categories > Life Sciences > Pharmaceuticals > Research & Development
(10 reports matching your criteria)
 
Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets
11/30/2012 | published by: Decision Resources
... by a growing prevalent population with greater access to medical care and by rheumatologists’ increasing use of more aggressive treatments. Increased government spending on healthcare and improved penetration of biological agents make this an attractive ...  |  read more...
$10,000.00
Brazil Pharmaceutical Market Overview – Strong market growth continues, but regulatory risks increase
9/21/2012 | published by: Datamonitor
... slowing sales growth in more developed markets. Scope Analysis of population demographics, economic wealth, disease burden, level of industrialization, and political structure in Brazil. Insight into the healthcare system, drug regulation, drug pricing, drug reimbursement, ...  |  read more...
$5,700.00
Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing
7/1/2012 | published by: GBI Research
... MNCs to Partner with Local Players Resulting in Profit and Control Sharing” provides an in-depth analysis of the trends, issues and challenges in the pharmaceutical market in Brazil. The report analyzes the overall pharmaceutical and ...  |  read more...
$3,500.00
Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue
6/25/2012 | published by: GBI Research
... the Market with More Than 55% of the Industry Revenue” provides in-depth analysis of trends, issues and challenges in the pharmaceutical market in Argentina. The report analyzes the overall pharma and clinical trials market in ...  |  read more...
$3,500.00
New Emerging R&D and Clinical Trial Locations
1/4/2012 | published by: Business Insights
... offshoring and outsourcing destinations. Features and benefits Compare 5 new emerging R&D locations in terms of population, economic activity, healthcare infrastructure, and current R&D activity. Analyze how clinical trial numbers are changing in China, India, ...  |  read more...
$3,835.00
The Market for Pharmaceuticals in Brazil, Russia, India & China
3/31/2011 | published by: Espicom Healthcare Intelligence
... forecasts to 2014 are provided, plus free quarterly-updated market outlook reports on each country, keeping you up to date with developments for a full year. Please note, this file is delivered as an Zip file.  |  read more...
$3,490.00
Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
5/25/2010 | published by: Datamonitor
... coverage coupled with a growing affluent middle class and private sector have turned countries like Brazil, Russia or India into a promising commercial opportunity. Scope Analysis of current HIV market dynamics across Brazil, Russia and ...  |  read more...
$3,800.00
Emerging Clinical Trial Locations -latin America: Market Dynamics And The Changing Healthcare And Regulatory Environment
6/1/2009 | published by: Business Insights
... that the current business models have become both economically unsustainable and operationally unsuited to act quickly enough to produce the types of innovative treatments that will be demanded by global markets. Major issues confronting both ...  |  read more...
$3,835.00
Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.)
11/1/2007 | published by: Kalorama Information
... problems. This provides an opportunity for BRIC countries and other developing regions to grab a piece of the clinical trial market. Countries such as India and China have a vast population who are interested in ...  |  read more...
Buy by the section  | 
$1,500.00
Latin American Oncology Therapeutics Markets
1/10/2007 | published by: Frost & Sullivan
... a comprehensive quantitative analysis covering current market size, market share and a 5-year market forecast for the three countries covered in the study. In this study, Frost & Sullivan's expert analysts thoroughly examine the following ...  |  read more...
$6,000.00